View Older Stories View More Recent Stories

Feb 17, 2015 04:28PM Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:28PM Form SC 13G/A SANUWAVE Health, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:28PM Form SC 13G/A TherapeuticsMD, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:27PM Form SC 13G/A PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:27PM Form SC 13G/A AmpliPhi Biosciences Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:27PM Form SC 13G/A DYAX CORP Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:27PM Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:27PM Form SC 13G/A Mirati Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:27PM Form SC 13G/A Furiex Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:14PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31

Jan 30, 2015 04:50PM Form SC 13G AGILE THERAPEUTICS INC Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 20, 2015 05:06PM Form SC 13G TEKMIRA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 20, 2015 05:05PM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 20, 2015 05:03PM Form SC 13D/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 20, 2015 08:06AM Agile Therapeutics (AGRX) Announces $20M Private Placement; Updates Phase 3 SECURE Study

Dec 12, 2014 04:18PM Form SC 13G TREVENA INC Filed by: RA CAPITAL MANAGEMENT, LLC

Nov 14, 2014 04:24PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30

Nov 7, 2014 04:55PM Form SC 13G Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 31, 2014 05:29PM Form SC 13G PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 17, 2014 04:28PM RA Capital Management Shows New 8.3% Stake in TG Therapeutics (TGTX)

Oct 17, 2014 04:21PM Form SC 13G TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 26, 2014 05:27PM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 26, 2014 04:51PM Form SC 13G TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 3, 2014 03:05PM Notable 52-Week Highs and Lows of the Day 9/4: (MBLY) (ACHN) (FLEX) High; (MBII) (WTSL) (IRMD) Low

Sep 3, 2014 09:26AM Pre-Open Stock Movers 9/3: (ISNS) (INFI) (BTH) Higher; (END) (DGLY) (HELE) Lower (more...)

Sep 3, 2014 07:20AM RA Capital Management Changes Filing Status on Achillion Pharma (ACHN) to 13G

Sep 2, 2014 05:17PM Form SC 13G ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 2, 2014 05:15PM Form 4 ACHILLION PHARMACEUTICAL For: Aug 28 Filed by: RA CAPITAL MANAGEMENT, LLC

Aug 29, 2014 04:36PM Form SC 13G WaferGen Bio-systems, Filed by: RA CAPITAL MANAGEMENT, LLC

Aug 28, 2014 07:45AM RA Capital Management Lowers Stake in Achillion Pharma (ACHN) to 19.0%

Aug 27, 2014 05:25PM Form SC 13D/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC

Aug 20, 2014 05:22PM Form SC 13D/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC

Aug 19, 2014 05:11PM Form SC 13G VICAL INC Filed by: RA CAPITAL MANAGEMENT, LLC

Aug 14, 2014 04:17PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30

Jul 9, 2014 01:21PM PlacementTracker Publishes First Half 2014 PIPE Market League Tables

May 2, 2014 03:32PM RA Capital Management, LLC Raises Stake in Dyax Corp (DYAX) to 6.6%

Apr 8, 2014 11:00AM PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables

Mar 24, 2014 05:14PM RA Capital Management Raises Stake in pSivida Corp. (PSDV) to 8.8%

Mar 18, 2014 08:30AM SANUWAVE Closes $10.1M Private Placement Led by RA Capital Management

Feb 5, 2014 11:36AM RA Capital Shows New 7.2% Stake in Momo Stock Furiex Pharmaceuticals (FURX)

Jan 8, 2014 01:42PM PlacementTracker Publishes 2013 PIPE Market League Tables

May 13, 2013 07:17AM Dyax Corp. (DYAX) Prices $30M Direct Offering at $2.30/Share

Mar 4, 2013 04:32PM RA Capital Management Shows New 5.2% Stake in Hyperion Therapeutics (HPTX)

Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

Avilar Therapeutics Launches With $60 Million Seed Financing to Pioneer Extracellular Protein Degradation

View More Recent Stories View Older Stories